A Study to Evaluate the Safety, Tolerability, PK and PD of HNC1058
Clinical trial NCT05803850 · COMPLETED
Trial details
- NCT number
- NCT05803850
- Sponsor
- Guangzhou Henovcom Bioscience Co. Ltd.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-03-28
- Primary completion
- 2024-02-27
- Enrollment
- 32
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.